IRCT20170609034406N3 IRCT 2019-09-21 Tabriz University of Medical Sciences Effect of pentoxifylline on inflammatory factors and quality of life in hemodialysis patients Effect of pentoxifylline on inflammatory factors and quality of life in hemodialysis patients 2019-04-21 anticipated 100 Complete https://irct.ir/trial/38156 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, Permuted Block Randomization method was used for entering patients in control and treatment groups. In this method, each block contained an equal number of treatment groups and control group. Random numbers in this study were given using the Excel program to determine random blocks and random groups, Blinding description: This study is conducted in a single blind clinical trial. None of the people distributing drugs and patients are aware of which patients receive the drug or placebo, and are only diagnosed with the numbers given by the system to the patients. N/A End Stage Renal Disease. Intervention 1: Intervention group: The treatment group consists of 50 patients receiving 400 mg orally of Pentoxifylline daily for 3 months. Intervention 2: Control group consisted of 50 patients receiving 400 mg orally of placebo(which apart from the active ingredient,were similar to Pentoxifylline tablets )daily for 3 months. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information